SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Andersen BL, Farrar WB, Golden-Kreutz D, et al. Stress and immune responses after surgical treatment for regional breast cancer. J Natl Cancer Inst. 1998; 90: 3036.
  • 2
    Anisman H, Ravindran A, Griffiths J, Merali Z. Endocrine and cytokine correlates of major depression and dsythymia with typical or atypical features. Mol Psychiatr. 1999; 4: 182188.
  • 3
    Herbert T, Cohen S. Depression and immunity: a meta-analytic review. Psychol Bull. 1993; 113: 472486.
  • 4
    Herbert T, Cohen S. Stress and immunity in humans: a meta-analytic review. Psychosom Med. 1993; 55: 364379.
  • 5
    Glaser R, MacCallum R, Laskowski B, Malarkey W, Sheridan J, Kiecolt-Glaser J. Evidence for a shift in the Th-1 to Th-2 cytokine response associated with chronic stress and aging. J Gerontol A Biol Sci Med Sci. 2001; 56: M477M482.
  • 6
    Glaser R, Kiecolt-Glaser JK, Marucha PT, MacCallum RC, Laskowski BF, Malarkey WB. Stress-related changes in proinflammatory cytokine production in wounds. Arch Gen Psychiatr. 1999; 56: 450456.
  • 7
    Guidi L, Bartoloni C, Frasca D, et al. Impairment of lymphocyte activities in depressed aged subjects. Mech Ageing Dev. 1991; 60: 1324.
  • 8
    Elenkov I, Chrousos G. Stress, cytokine patterns and susceptibility to disease. Best Pract Res Clin Endocrinol Metab. 1999; 13: 583595.
  • 9
    Irwin M. Immune correlates of depression. Adv Exp Med Biol. 1999; 461: 124.
  • 10
    Lutgendorf S, Garand L, Buckwalter K, Tripp-Reimer T, Hong S, Lubaroff D. Life stress, mood disturbance, and elevated IL-6 in healthy older women. J Gerontol A Biol Sci Med Sci. 1999; 54: M434M439.
  • 11
    Goebel M, Mills P, Irwin M, Ziegler M. Interleukin-6 and tumor necrosis factor-alpha production after acute psychological stress, exercise, and infused isoproterenol: differential effects and pathways. Psychosom Med. 2000; 62: 591598.
  • 12
    Baron R, Cutrona C, Hicklin D, Russel D, Lubaroff D. Social support and immune function among spouses of cancer patients. J Pers Soc Psychol. 1990; 59: 344352.
  • 13
    Kiecolt-Glaser J, Glaser R, Cacioppo J, Malarkey W. Marital stress: immunologic, neuroendocrine, and autonomic correlates. Ann NY Acad Sci. 1998; 840: 656663.
  • 14
    Uchino B, Cacioppo J, Kiecolt-Glaser J. The relationship between social support and physiological processes: a review with emphasis on underlying mechanisms and implications for health. Psychol Bull. 1996; 119: 488531.
  • 15
    Kiecolt-Glaser J, Malarkey W, Cacioppo J, Glaser R. Stressful personal relationships: endocrine and immune function. In: GlaserR, Kiecolt-GlaserJ, editors. Handbook of human stress and immunity. San Diego: Academic Press, 1994: 321339.
  • 16
    Madden KS. Catecholamines, sympathetic nerves, and immunity. In: AderR, FeltenD, CohenN, editors. Psychoneuroimmunology, vol 1, 3rd ed. San Diego: Academic Press, 2001: 197216.
  • 17
    Chrousos G. The hypothalamic-pitiutiary-adrenal axis and immune-mediated inflammation. N Engl J Med. 1992; 332: 13511362.
  • 18
    Dhabhar F, McEwen B. Bidirectional effects of stress and glucocorticoid hormones on immune function: possible explanations for paradoxical observations. In: AderR, FeltenD, CohenN, editors. Psychoneuroimmunology, vol 1, 3rd ed. San Diego: Academic Press, 2001: 301338.
  • 19
    Carr DJ, Weber RJ. Opioidergic modulation of the immune system. In: AderR, FeltenD, CohenN, editors. Psychoneuroimmunology, vol 1. San Diego: Academic Press, 2001: 405414.
  • 20
    Venters HD, Dantzer R, Freund GG, Broussard SR, Kelley KW. Growth hormone and insulin-like growth factor as cytokines in the immune system. In: AderR, FeltenD, CohenN, editors. Psychoneuroimmunology, vol 1, 3rd ed. San Diego: Academic Press, 2001: 339362.
  • 21
    Cohen S, Rabin B. Psychological stress, immunity, and cancer. J Natl Cancer Inst. 1998; 90: 34.
  • 22
    Fawzy F, Kemeny M, Fawzy N, et al. A structured psychiatric intervention for cancer patients. II. Changes over time in immunological measures. Arch Gen Psychiatr. 1990; 47: 729735.
  • 23
    Ben-Eliyahu S, Page G, Yirmiya R, Shakhar G. Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity. Int J Cancer. 1999; 80: 880888.
  • 24
    Shakhar G, Ben-Eliyahu S. In vivo beta-adrenergic stimulation suppresses natural killer activity and compromises resistance to tumor metastasis in rats. J Immunol. 1998; 160: 32513258.
  • 25
    Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst. 1990; 82: 46.
  • 26
    Kerbel R. Tumor angiogenesis: past, present, and the near future. Carcinogenesis. 2000; 21: 505515.
  • 27
    Folkman J. Tumor angiogenesis. In: MendelsohnJ, HowleyPM, IsraelMA, LiottaLA, editors. The molecular basis of cancer. Philadelphia: WB Saunders, 1995: 206232.
  • 28
    Lewin M, Bredow S, Sergeyev N, Marecos E, Bogdanov A, Weissleder R. In vivo assessment of vascular endothelial growth factor-induced angiogenesis. Int J Cancer. 1999; 83: 798802.
  • 29
    McCourt M, Wang J, Sookhai S, Redmond H. Proinflammatory mediators stimulate neutrophil-directed angiogenesis. Arch Surg. 1999; 134: 13251332.
  • 30
    Inoue M, Itoh H, Tanaka T, et al. Oxidized LDL regulates vascular endothelial growth factor expression in human macrophages and endothelial cells through activation of peroxisome proliferator-activated receptor-gamma. Arterioscleros Thromb Vasc Biol. 2001; 21: 560566.
  • 31
    Wartiovaara U, Salven P, Mikkola H, et al. Peripheral blood platelets express VEGF-C and VEGF which are released during platelet activation. Thromb Haemost. 1998; 80: 171175.
  • 32
    Brown L, Detmar M, Claffey K, et al. Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine. EXS. 1997; 79: 233269.
  • 33
    Kraft A, Weindel K, Ochs A, et al. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease. Cancer. 1999; 85: 178187.
  • 34
    Paley PJ, Staskus KA, Gebhard K, Mohanraj D, Twiggs LB, Carson LF. Vascular endothelial growth factor expression in early stage ovarian carcinoma. Cancer. 1997; 80: 98106.
  • 35
    Sood AK, Holmes R, Sorosky JI, Anderson B, Buller RE. Preoperative serum vascular endothelial growth factor (VEGF) levels: significance in ovarian cancer. Presentation at the annual meeting of the Western Association of Gynecologic Oncologists. 1999.
  • 36
    Dankbar B, Padro T, Leo R, et al. Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cells interactions in multiple myeloma. Blood. 2000; 95: 26302636.
  • 37
    Saito H, Tsujitani S, Oka S, et al. The expression of transforming growth factor-beta-1 is significantly correlated with the expression of vascular endothelial growth factor and poor prognosis of patients with advanced gastric carcinoma. Cancer. 1999; 86: 14551462.
  • 38
    Cullinan-Bove K, Koos RD. Vascular endothelial growth factor/vascular permeability factor expression in the rat uterus: rapid stimulation by estrogen correlates with extrogen-induced increases in uterine capillary permeability and growth. Endocrinology. 1993; 133: 829837.
  • 39
    Shweiki D, Itin A, Neufeld G, Gitay-Goren H, Keshet E. Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis. J Clin Invest. 1993; 91: 22352243.
  • 40
    Tonello C, Giordano A, Cozzi V, et al. Role of sympathetic activity in controlling the expression of vascular endothelial growth factor in brown fat cells of lean and genetically obese rats. FEBS Lett. 1999; 442: 167172.
  • 41
    Asano A, Morimatsu M, Nikami H, Yoshida T, Saito M. Adrenergic activation of vascular endothelial growth factor mRNA expression in rat brown adipose tissue: implication in cold-induced angiogenesis. Biochem J. 1997; 328: 179183.
  • 42
    Fredriksson JM, Lindquist JM, Bronnikov G, Nedergaard J. Norepinephrine induces vascular endothelial growth factor gene expression in brown adipocytes through a beta-adrenoreceptor/cAMP/protein kinase A pathway involving Src but independently of Erk1/2. J Biol Chem. 2000; 275: 1380213811.
  • 43
    Basu S, Nagy JA, Pal S, et al. The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor. Nat Med. 2001; 7: 569574.
  • 44
    Lutgendorf S, Anderson B, Buller R, Sorosky J, Lubaroff D. Interleukin-6 and social support in gynecologic cancer patients. Int J Behav Med. 2000; 7: 127142.
  • 45
    Frommberger U, Bauer J, Haselbauer P, Fraulin A, Riemann D, Berger M. Interleukin-6 (IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission. Eur Arch Psychiatr Clin Neurosci. 1997; 247: 228233.
  • 46
    Zhou D, Kusnecov A, Shurin M, dePaoli M, Rabin B. Exposure to physical and psychological stressors elevates plasma interleukin-6: Relationship to the activation of hypothalamic-pituitary-adrenal axis. Endocrinology. 1993; 133: 25232530.
  • 47
    Lutgendorf S, Garand L, Buckwalter K, Tripp Reimer T, Hong S-Y, Lubaroff D. Life stress, mood disturbance, and elevated interleukin-6 in healthy older women. J Gerontol A Biol Sci Med Sci. 1999; 54 A:M1M6.
  • 48
    Maes M, Bosmans E, de Jongh R, Kenis G, Vandoolaeghe E, Neels H. Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine. 1997; 9: 853858.
  • 49
    Sluzewska A, Rybakowski J, Laciak M, Mackiewicz A, Sobieska M, Wiktorowicz K. Interleukin-6 levels in depressed patients before and after treatment with fluoxetine. Ann NY Acad Sci. 1995; 762: 474476.
  • 50
    Cohen S, Wills T. Stress, social support, and the buffering hypothesis. Psychol Bull. 1985; 98 (2): 310357.
  • 51
    Brummett B, Barefoot J, Siegler I, et al. Characteristics of socially isolated patients with coronary artery disease who are at elevated risk for mortality. Psychosom Med. 2001; 63: 267272.
  • 52
    House JS, Landis KR, Umberson D. Social relationships and health. Science. 1988; 241: 540545.
  • 53
    Leserman J, Petitto J, Golden R, et al. Impact of stressful life events, depression, social support, coping, and cortisol on progression to AIDS. Am J Psychiatr. 2000; 157: 12211228.
  • 54
    McEwen B. Stress, adaptation and disease. Allostasis and allostatic load. Ann NY Acad Sci. 1998; 840: 3344.
  • 55
    Cella D, Tulsky D, Gray G. Development and validation of the general measure. J Clin Oncol. 1993; 11: 570579.
  • 56
    McNair DM, Lorr M, Droppleman LF. EITS manual for the profile of mood states. San Diego: Educational and Industrial Testing Service, 1971.
  • 57
    Andersen B, Anderson B, deProsse C. Controlled prospective longitudinal study of women with cancer: II. Sexual functioning outcomes. J Consult Clin Psychol. 1989; 57: 692697.
  • 58
    Lutgendorf S, Anderson B, Ullrich P, et al. Quality of life and mood in women with gynecologic cancer: a one year prospective study. Cancer. 2002; 94: 131140.
  • 59
    Kiecolt-Glaser J, Malarkey W, Chee M, et al. Negative behavior during marital conflict is associated with immunological down-regulation. Psychosom Med. 1993; 55: 395409.
  • 60
    Esterling B, Kiecolt-Glaser J, Bodnar J, Glaser R. Chronic stress, social support, and persistent alterations in the natural killer cell response to cytokines in older adults. Health Psychol. 1994; 13: 291298.
  • 61
    Turner-Cobb J, Sephton S, Koopman C, Blake-Mortimer J, Spiegel D. Social support and salivary cortisol in women with metastatic breast cancer. Psychosom Med. 2000; 62: 337345.
  • 62
    Cruess D, Leserman J, Petitto J, et al. Psychosocial-immune relationships in HIV disease. Semin Clin Neuropsychiatr. 2001; 6: 241251.
  • 63
    Seeman TE, Berkman LF, Blazer D, Rowe JW. Social ties and support and neuroendocrine function: the MacArthur studies of successful aging. Ann Behav Med. 1994; 16: 95106.
  • 64
    Seeman T, McEwen B. Impact of social environment characteristics on neuroendocrine regulation. Psychosom Med. 1996; 58: 459471.
  • 65
    Antoni M, Cruess D, Wagner S, et al. Cognitive behavioral stress management reduces anxiety and 24-hour urinary catecholamine output among symptomatic HIV-infected gay men. J Consult Clin Psychol. 2000; 66: 3145.
  • 66
    Antoni M, Cruess S, Cruess D, et al. Cognitive-behavioral stress management reduces distress and 24-hour urinary free cortisol output among symptomatic HIV-infected gay men. Ann Behav Med. 2000; 22: 2937.
  • 67
    Andersen B, Kiecolt-Glaser J, Glaser R. A biobehavioral model of cancer stress and disease course. Am Psychol. 1994; 49: 389404.